97 related articles for article (PubMed ID: 23775921)
1. First reviews are published that are based on the "totality of the evidence".
Kmietowicz Z
BMJ; 2013 Jun; 346():f3909. PubMed ID: 23775921
[No Abstract] [Full Text] [Related]
2. YODA and truth seeking in medicine.
Doshi P; Vedula SS; Li T
BMJ; 2013 Jul; 347():f4251. PubMed ID: 23819966
[No Abstract] [Full Text] [Related]
3. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research.
Carragee EJ; Baker RM; Benzel EC; Bigos SJ; Cheng I; Corbin TP; Deyo RA; Hurwitz EL; Jarvik JG; Kang JD; Lurie JD; Mroz TE; Oner FC; Peul WC; Rainville J; Ratliff JK; Rihn JA; Rothman DJ; Schoene ML; Spengler DM; Weiner BK
Spine J; 2012 Oct; 12(10):877-80. PubMed ID: 23199819
[No Abstract] [Full Text] [Related]
4. [Too good to be true].
Brox JI
Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2228-9. PubMed ID: 22085945
[No Abstract] [Full Text] [Related]
5. Folly of FDA-approval studies for bone morphogenetic protein.
Mirza SK
Spine J; 2011 Jun; 11(6):495-9. PubMed ID: 21729798
[No Abstract] [Full Text] [Related]
6. Exposing conflicts of interest and complications of rhBMP-2.
Chi JH
Neurosurgery; 2011 Oct; 69(4):N21-2. PubMed ID: 21900807
[No Abstract] [Full Text] [Related]
7. Resetting standards for sponsored research: do conflicts influence results?
Spengler DM
Spine J; 2011 Jun; 11(6):492-4. PubMed ID: 21729797
[No Abstract] [Full Text] [Related]
8. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors.
Carragee EJ; Ghanayem AJ; Weiner BK; Rothman DJ; Bono CM
Spine J; 2011 Jun; 11(6):463-8. PubMed ID: 21729794
[No Abstract] [Full Text] [Related]
9. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
Lehman RA; Kang DG
Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
[No Abstract] [Full Text] [Related]
10. Medtronic submits full data on spinal protein to independent scrutiny.
Cohen D
BMJ; 2011 Aug; 343():d5484. PubMed ID: 21878463
[No Abstract] [Full Text] [Related]
11. Important considerations on bone morphogenetic protein-2 and neuroinflammation.
Heggeness MH
Spine J; 2011 Jun; 11(6):506. PubMed ID: 21729800
[No Abstract] [Full Text] [Related]
12. Another complication associated with rhBMP-2?
Kang JD
Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
[No Abstract] [Full Text] [Related]
13. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
Smoljanovic T; Bojanic I
Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
[No Abstract] [Full Text] [Related]
14. Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned".
Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
Spine J; 2011 Nov; 11(11):1082-3; author reply 1083-6. PubMed ID: 22078853
[No Abstract] [Full Text] [Related]
15. Re: A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
Woo EJ
Spine J; 2011 Aug; 11(8):804; author reply 804-5. PubMed ID: 21925424
[No Abstract] [Full Text] [Related]
16. Letter to the editor regarding "A critical review of recombinant human morphogenetic protein-2 trials in spine surgery: emerging safety concerns and lessons learned".
Anderson PA
Spine J; 2012 Apr; 12(4):356; author reply 356-7; discussion 357-9. PubMed ID: 22464143
[No Abstract] [Full Text] [Related]
17. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?
Resnick D; Bozic KJ
Ann Intern Med; 2013 Jun; 158(12):912-3. PubMed ID: 23778909
[No Abstract] [Full Text] [Related]
18. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
[TBL] [Abstract][Full Text] [Related]
19. Vertebral body osteolysis after minimal-access transforaminal interbody fusion.
Lehman RA
Spine J; 2011 Jun; 11(6):581-2. PubMed ID: 21729806
[No Abstract] [Full Text] [Related]
20. RE: complications attributable to the use of rhBMP-2 inside the femoral ring allograft during anterior lumbar interbody fusion.
Smoljanovic T; Pecina M
Spine J; 2008; 8(2):413-4; author reply 414. PubMed ID: 18178134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
